Cor Lieftink
Impact in
- Oncology top 2%
- Molecular Biology top 2%
- Melanoma and MAPK Pathways
- Bioinformatics and Genomic Networks
- Protein Tyrosine Phosphatases
- CRISPR and Genetic Engineering
Papers in
-
- DNA Repair Mechanisms 8
- CRISPR and Genetic Engineering 8
- Melanoma and MAPK Pathways 8
- Protein Degradation and Inhibitors 6
- RNA Research and Splicing 5
- PI3K/AKT/mTOR signaling in cancer 5
- Oncology 19
- Cancer-related Molecular Pathways 8
- Co-authors
- Rene Bernards (25 shared papers)Roderick L. Beijersbergen (44 shared papers)Cun Wang (7 shared papers)Bastiaan Evers (5 shared papers)Alberto Bardelli (3 shared papers)Sara Mainardi (4 shared papers)Liqin Wang (8 shared papers)Wenxin Qin (6 shared papers)
- Journals
- Cell Reports (7 papers)Nucleic Acids Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)Molecular Cancer Therapeutics (3 papers)Cell Reports Medicine (3 papers)
- Partner nations
- NetherlandsChinaUnited States
In The Last Decade
Cor Lieftink
63 papers receiving 4.8k citations
Cor Lieftink's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.3k
- Molecular Biology 3.2k
- Cancer Research 604
- Immunology 761
- Aging 42
Countries citing papers authored by Cor Lieftink
This map shows the geographic impact of Cor Lieftink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor Lieftink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor Lieftink more than expected).
Fields of papers citing papers by Cor Lieftink
This network shows the impact of papers produced by Cor Lieftink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor Lieftink. The network helps show where Cor Lieftink may publish in the future.
Co-authors
The 25 scholars most cited alongside Cor Lieftink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma Hit paper breakdown → | 2014 | 691 |
| 2 | IntAct--open source resource for molecular interaction data Hit paper breakdown → | 2006 | 644 |
| 3 | EGFR activation limits the response of liver cancer to lenvatinib Hit paper breakdown → | 2021 | 354 |
| 4 | Inducing and exploiting vulnerabilities for the treatment of liver cancer Hit paper breakdown → | 2019 | 345 |
| 5 | 2018 | 324 | |
| 6 | 2018 | 269 | |
| 7 | 2014 | 265 | |
| 8 | 2017 | 187 | |
| 9 | 2020 | 150 | |
| 10 | 2015 | 136 | |
| 11 | 2014 | 99 | |
| 12 | 2019 | 92 | |
| 13 | 2018 | 89 | |
| 14 | 2018 | 76 | |
| 15 | 2016 | 73 | |
| 16 | 2021 | 71 | |
| 17 | 2016 | 69 | |
| 18 | 2017 | 68 | |
| 19 | 2021 | 58 | |
| 20 | 2018 | 51 |
About Cor Lieftink
Cor Lieftink is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Immunology, having authored 68 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (8 papers), CRISPR and Genetic Engineering (8 papers), Melanoma and MAPK Pathways (8 papers), Protein Degradation and Inhibitors (6 papers), Cancer Mechanisms and Therapy (6 papers), RNA Research and Splicing (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Oncology (1.3k citations), Molecular Biology (3.2k citations), Cancer Research (604 citations), Immunology (761 citations) and Aging (42 citations). Cor Lieftink has collaborated with scholars based in Netherlands, China and United States. Frequent co-authors include Rene Bernards, Roderick L. Beijersbergen, Cun Wang, Bastiaan Evers, Alberto Bardelli, Sara Mainardi, Liqin Wang, Wenxin Qin, Haojie Jin and Giovanni Germano. Their work appears in journals such as Cell Reports, Nucleic Acids Research, Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.